1 / 29

Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?

Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?. Panelists. Learning Objectives. Learning Objectives. Diabetes as a CV Risk Factor. Impact of Gluco-Metabolic Characteristics on Risk of Major Cardiovascular Events.

millie
Download Presentation

Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?

  2. Panelists

  3. Learning Objectives

  4. Learning Objectives

  5. Diabetes as a CV Risk Factor

  6. Impact of Gluco-Metabolic Characteristics on Risk of Major Cardiovascular Events

  7. Risk Factors in Patients With T2D After ACS

  8. The HDL Hypothesis

  9. Meta-analysis of Intensive Statin Trials:Coronary Death or Myocardial Infarction

  10. Intensive Glucose Control in Critically Ill Patients: Death From Any Cause

  11. UKPDS: Extended Follow-up Benefits of Glycemic Control

  12. Comparison of CETP Inhibitors

  13. DAL-OUTCOMES: 3 Years

  14. AIM-HIGH: End Point at 36-month Follow-up

  15. ACCORD Lipid: Hazard Ratios for the Primary Outcome

  16. SYNCHRONY: Effect of Aleglitazar on Cardiometabolic Parameters in T2D

  17. AleCardio: Aleglitazar in Patients With T2D and ACS

  18. Unmet Needs: Diabetes in Post-ACS Patients

  19. Abbreviations

  20. Abbreviations (cont)

  21. Abbreviations (cont)

  22. References

  23. References (cont)

  24. References (cont)

  25. References (cont)

More Related